245 related articles for article (PubMed ID: 16026280)
1. Antiphospholipid syndrome: characteristics and obstetrical management.
Nishiguchi T; Kobayashi T
Curr Drug Targets; 2005 Aug; 6(5):593-605. PubMed ID: 16026280
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S; McCrae KR
Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
[TBL] [Abstract][Full Text] [Related]
3. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibody syndrome.
Kutteh WH; Hinote CD
Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
9. The antiphospholipid syndrome: still an enigma.
Chaturvedi S; McCrae KR
Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
[TBL] [Abstract][Full Text] [Related]
10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
11. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Ernest JM; Marshburn PB; Kutteh WH
Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
[TBL] [Abstract][Full Text] [Related]
12. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
13. Management of maternal antiphospholipid syndrome.
Fernandes MA; Gerardi MC; Andreoli L; Tincani A
Clin Exp Rheumatol; 2020; 38(1):149-156. PubMed ID: 31287415
[TBL] [Abstract][Full Text] [Related]
14. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?
Marchetti T; Cohen M; Gris JC; de Moerloose P
Pol Arch Med Wewn; 2013; 123(12):713-20. PubMed ID: 24382555
[TBL] [Abstract][Full Text] [Related]
16. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.
Chighizola CB; Gerosa M; Trespidi L; Di Giacomo A; Rossi F; Acaia B; Meroni PL
Expert Rev Clin Immunol; 2014 Nov; 10(11):1505-17. PubMed ID: 25300673
[TBL] [Abstract][Full Text] [Related]
17. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy of antiphospholipid syndrome.
Sherer Y; Levy Y; Shoenfeld Y
Rheumatology (Oxford); 2000 Apr; 39(4):421-6. PubMed ID: 10817776
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
[TBL] [Abstract][Full Text] [Related]
20. Current insights in obstetric antiphospholipid syndrome.
Schreiber K; Radin M; Sciascia S
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
